+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Rhythm Management Market Analysis, Size, Trends | United States | 2019-2025

  • ID: 4876622
  • Report
  • August 2019
  • Region: United States
  • 518 Pages
  • iData Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • Biosense Webster
  • Biotronik
  • Boston Scientific
  • Cardiac Science
  • GE Healthcare
  • MORE
In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR in the mid single digits.

This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators, electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Biosense Webster
  • Biotronik
  • Boston Scientific
  • Cardiac Science
  • GE Healthcare
  • MORE
TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

1. EXECUTIVE SUMMARY

U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW

2.1 INTRODUCTION
2.2 TYPES OF ARRHYTHMIAS
2.2.11 Atrial Fibrillation
2.2.12 Bradycardia
2.2.13 Conduction Disorders
2.2.13.1 Bundle Branch Block
2.2.13.2 Heart Block
2.2.13.3 Long QT Syndrome (LQTS)
2.2.14 Premature Contractions: PACs and PVCs
2.2.15 Tachycardia
2.2.16 Ventricular Fibrillation
2.2.17 Other Rhythm Disorders
2.2.17.1 Adams-Stokes Disease
2.2.17.2 Atrial Flutter
2.2.17.3 Sick Sinus syndrome
2.2.17.4 Sinus Arrhythmia
2.2.17.5 Wolff-Parkinson-White Syndrome (WPW)
2.2.18 Types of Arrhythmia in Children
2.3 HEART FAILURE
2.4 CARDIAC ARREST
2.5 PATIENT DEMOGRAPHICS
2.5.11 Atrial Fibrillation
2.5.12 Bradycardia
2.5.13 Conduction Disorders
2.5.14 Premature Contractions – PACs and PVCs
2.5.15 Tachycardia
2.5.16 Ventricular Fibrillation
2.5.17 Other Rhythm Disorders

3. PRODUCT ASSESSMENT

3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Pacemakers
3.2.2 Implantable Cardioverter Defibrillators (ICDs)
3.2.3 Cardiac Resynchronization Therapy (CRT) Devices
3.2.4 Cardiac Leads
3.2.5 External Defibrillators
3.2.6 Lab Systems
3.2.6.1 Introduction
3.2.6.2 3D Mapping Systems
3.2.6.3 EP Recording Systems
3.2.6.4 Remote Steering Systems
3.2.6.5 RF Ablation Generator
3.2.6.6 ICE Systems
3.2.6.7 Product Matrix for Lab Systems: Core Companies
3.2.7 Diagnostic EP Catheters
3.2.7.1 Introduction
3.2.7.2 Diagnostic EP Catheters
3.2.7.3 ICE Catheters
3.2.8 Cardiac Ablation Catheters
3.2.8.1 Introduction
3.2.8.2 RF Ablation Catheters
3.2.8.3 Alternative Energy Catheters
3.2.8.4 High Intensity Focused Ultrasound
3.3 FDA RECALLS
3.3.1 Abbott
3.3.1.1 Pacemakers
3.3.1.2 Implantable Cardioverter Defibrillators (ICDs)
3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices
3.3.1.4 Cardiac Leads
3.3.1.5 EP Lab Devices
3.3.1.6 Cardiac Ablation Catheter
3.3.2 Biosense Webster
3.3.2.1 EP Lab Devices
3.3.3 Boston Scientific
3.3.3.1 Pacemakers
3.3.3.2 Implantable Cardioverter Defibrillators (ICDs)
3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices
3.3.3.4 Cardiac Leads
3.3.3.5 EP Lab Devices
3.3.3.6 RF Ablation Catheter
3.3.4 Cardiac Science
3.3.4.1 Automated External Defibrillator (AED)
3.3.5 Medtronic
3.3.5.1 Pacemakers
3.3.5.2 Implantable Cardioverter Defibrillators (ICDs)
3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices
3.3.5.4 Cardiac Leads
3.3.5.5 EP Lab Devices
3.3.6 MicroPort
3.3.6.1 Implantable Cardioverter Defibrillators (ICDs)
3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices
3.3.7 Philips Healthcare
3.3.7.1 Automated External Defibrillator (AED)
3.3.8 Stryker Sustainability Solutions
3.3.8.1 Diagnostic EP Catheters
3.3.9 ZOLL
3.3.9.1 Automated External Defibrillator (AED)
3.3.9.2 Wearable Cardioverter Defibrillator (WCD)
3.4 CLINICAL TRIALS
3.4.1 Pacemakers
3.4.2 Implantable Cardioverter Defibrillators (ICDs)
3.4.3 Cardiac Resynchronization Therapy (CRT) Devices
3.4.4 Cardiac Leads
3.4.5 External Defibrillators
3.4.6 Lab Systems
3.4.6.1 3D Mapping Systems
3.4.6.2 EP Recording Systems
3.4.6.3 RF Ablation Generators
3.4.6.4 ICE Systems
3.4.7 Diagnostic EP Catheters
3.4.7.1 Diagnostic Catheter
3.4.8 Cardiac Ablation Catheter
3.4.8.1 RF Ablation Catheters
3.4.8.2 Cryoablation Catheters
3.4.8.3 Laser Ablation Catheters

4. U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 TREND ANALYSIS BY SEGMENT
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
4.6 MERGERS AND ACQUISITIONS
4.7 COMPANY PROFILES
4.7.1 Abbott
4.7.2 Biosense Webster
4.7.3 Biotronik
4.7.4 Boston Scientific
4.7.5 Cardiac Science
4.7.6 GE Healthcare
4.7.7 Medtronic
4.7.8 MicroPort
4.7.9 ZOLL
4.8 SWOT ANALYSIS
4.8.1 Abbott
4.8.2 Biosense Webster
4.8.3 Biotronik
4.8.4 Boston Scientific
4.8.5 Cardiac Science
4.8.6 GE Healthcare
4.8.7 Medtronic
4.8.8 MicroPort
4.8.9 ZOLL

5. PROCEDURE NUMBERS

5.1 INTRODUCTION
5.2 PROCEDURES
5.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures

6. PACEMAKER MARKET

6.1 INTRODUCTION
6.1.1 Single and Dual-Chamber Devices
6.1.2 MRI-Compatible Pacemaker
6.1.3 Leadless Pacemaker
6.1.4 Initial Placement and Replacement of Pacemakers
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Pacemaker Market
6.3.2 Total Single-Chamber Pacemaker Market
6.3.2.1 Initial Placement Single-Chamber Pacemaker Market
6.3.2.2 Replacement Single-Chamber Pacemaker Market
6.3.3 Total Dual-Chamber Pacemaker Market
6.3.3.1 Initial Placement Dual-Chamber Pacemaker Market
6.3.3.2 Replacement Dual-Chamber Pacemaker Market
6.3.4 Leadless Pacemaker Market
6.4 PRICE ANALYSIS
6.5 DRIVERS AND LIMITERS
6.5.1 Market Drivers
6.5.2 Market Limiters
6.6 COMPETITIVE MARKET SHARE ANALYSIS

7. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET

7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total ICD Market
7.3.2 Total Single-Chamber ICD Market
7.3.2.1 Initial Placement Single-Chamber ICD Market
7.3.2.2 Replacement Single-Chamber ICD Market
7.3.3 Total Dual-Chamber ICD Market
7.3.3.1 Initial Placement Dual-Chamber ICD Market
7.3.3.2 Replacement Dual-Chamber ICD Market
7.3.4 S-ICD Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS

8. CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET

8.1 INTRODUCTION
8.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
8.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total CRT Market
8.3.2 Total CRT-P Market
8.3.2.1 Initial Placement CRT-P Market
8.3.2.2 Replacement CRT-P Market
8.3.3 Total CRT-D Market
8.3.3.1 Initial Placement CRT-D Market
8.3.3.2 Replacement CRT-D Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS

9. CARDIAC LEADS MARKET

9.1 INTRODUCTION
9.1.1 Replacement of Leads
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Total Cardiac Lead Market
9.3.2 Pacing Lead Market
9.3.3 Defibrillation Lead Market
9.3.4 LV Lead Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS

10. ELECTROCARDIOGRAPHY MONITORING MARKET

10.1 INTRODUCTION
10.1.1 Holter Monitoring
10.1.2 Stress Testing
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Resting ECG Device Market
10.3.1.1 Hospital-Based Resting ECG Device Market
10.3.1.2 Total Office-Based Resting ECG Device Market
10.3.1.2.1 Purpose-Built Office-Based Resting ECG Device Market
10.3.1.2.2 PC-Based Office-Based Resting ECG Device Market
10.3.2 Total Stress Testing Device Market
10.3.2.1 Hospital-Based Stress Testing Device Market
10.3.2.2 Office-Based Stress Testing Device Market
10.3.3 Total Holter Monitoring Recorder Market
10.3.3.1 Hospital-Based Holter Monitoring Recorder Market
10.3.3.2 Office-Based Holter Monitoring Recorder Market
10.3.3.3 IDTF Holter Monitoring Recorder Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS

11. LAB SYSTEMS MARKET

11.1 INTRODUCTION
11.1.1 3D Mapping Systems
11.1.2 EP Recording Systems
11.1.3 Remote Steering Systems
11.1.4 RF Ablation Generator
11.1.5 ICE System
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 3D Mapping Market
11.3.2 EP Recording Market
11.3.3 RF Ablation Generator Market
11.3.4 Remote Steering System Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE MARKET SHARE ANALYSIS

12. DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS MARKET

12.1 INTRODUCTION
12.1.1 Diagnostic Electrophysiology Catheters
12.1.2 Reprocessed Catheters
12.1.3 Intracardiac Echocardiography
12.2 MARKET OVERVIEW
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Total Diagnostic Electrophysiology Catheters Market
12.3.2 Total EP Conventional Catheter Market
12.3.2.1 Fixed EP Catheter Market
12.3.2.2 Steerable EP Catheter Market
12.3.3 EP Advanced Catheter Market
12.3.4 ICE Diagnostic Catheter Market
12.4 DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE MARKET SHARE ANALYSIS

13. CARDIAC ABLATION CATHETER MARKET

13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Cardiac Ablation Catheter Market
13.3.2 RF Ablation Catheter Market
13.3.2.1 Irrigated RF Ablation Catheter Market
13.3.2.2 Non-Irrigated RF Ablation Catheter Market
13.3.3 Cryoablation Catheter Market
13.4 DRIVERS AND LIMITERS
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 COMPETITIVE MARKET SHARE ANALYSIS

14. APPENDIX I: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GENERATOR MARKET

14.1 INTRODUCTION
14.2 MARKET ANALYSIS AND FORECAST
14.3 DRIVERS AND LIMITERS
14.3.1 Market Drivers
14.3.2 Market Limiters
14.4 COMPETITIVE MARKET SHARE ANALYSIS

15. APPENDIX II: CRYOABLATION GENERATOR MARKET

15.1 INTRODUCTION
15.2 MARKET ANALYSIS AND FORECAST
15.3 DRIVERS AND LIMITERS
15.3.1 Market Drivers
15.3.2 Market Limiters
15.4 COMPETITIVE MARKET SHARE ANALYSIS

16. APPENDIX III: EXTERNAL DEFIBRILLATOR MARKET

16.1 INTRODUCTION
16.1.1 Automated External Defibrillator
16.1.2 Wearable Cardioverter Defibrillator
16.2 MARKET OVERVIEW
16.3 MARKET ANALYSIS AND FORECAST
16.3.1 Total External Defibrillator Market
16.3.2 Automated External Defibrillator Market
16.3.3 Wearable Cardioverter Defibrillator Market
16.4 DRIVERS AND LIMITERS
16.4.1 Market Drivers
16.4.2 Market Limiters
16.5 COMPETITIVE MARKET SHARE ANALYSIS

17. ABBREVIATIONS
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • Biosense Webster
  • Biotronik
  • Boston Scientific
  • Cardiac Science
  • GE Healthcare
  • Medtronic
  • MicroPort
  • ZOLL
Note: Product cover images may vary from those shown
Adroll
adroll